Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, a move investors said eases some concerns about signs of weakness in sales of its popular diabetes and weight-loss ...

With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global ...

Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

NEW YORK — Wall Street drifted through mixed trading Feb. 6 as rising fashion and cigarette stocks worked against drops for ...